1Y Close · As of Aug 26, 2026
HUONS operates in the Pharmaceuticals sector.
Legal name: HUONS CO., LTD.
In fiscal year 2025, HUONS (243070) reported revenue of 620.8 billion KRW, up 5.2% from 590.2 billion KRW a year earlier.
Operating profit was 45.6 billion KRW and net income was 42.2 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 297.1 billion KRW, with a P/B of 0.72.
These figures can be verified in the DART filing (receipt no. 20260323001636).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 620.8B | 45.6B | 42.2B |
| 2024 | 590.2B | 39.7B | 29.1B |
| 2023 | 552.0B | 56.0B | 50.4B |
Recent Filings
기타주요경영사항 (회사합병 결정 및 임시주주총회 소집결의 철회)
Corporate Briefing (IR)
Semi-Annual Report (2026.06)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-26 | 기타주요경영사항 (회사합병 결정 및 임시주주총회 소집결의 철회) |
| 2026-08-24 | Corporate Briefing (IR) |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-11 | Dividend Decision (Quarterly Dividend) |
| 2026-08-11 | 중간(분기)배당을위한주주명부폐쇄(기준일)결정 |